About the Regenerative Medicine Market
Regenerative medicine is a process of regenerating cells, tissues, and organs to restore normal function in a diseased organ. This branch of tissue engineering and molecular biology is promising and is driven by demand from patients, development of cell therapy, tissue scaffold, and gene therapy products, and increase in the number of pipeline products.
Technavio’s analysts forecast the global regenerative medicine market to grow at a CAGR of 20.7% during the period 2016-2020.
Covered in this report
The report covers the present scenario and the growth prospects of the global regenerative medicine market for 2016-2020. To calculate the market size, we used the revenue generated from the sales of various types of regenerative medicine products.
The market is divided into the following segments based on geography:
• Americas
• APAC
• EMEA
Technavio's report, Global Regenerative Medicine Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
Key vendors
• Acelity
• Medtronic
• MiMedx Group
• Organogenesis
• UniQure
• Zimmer Biomet
Other prominent vendors
• ACE Surgical Supply
• Acologix
• Advanced Biologics
• AlloCure
• Allosource
• Alphatec Spine
• Altrika
• Amorcyte
• Anterogen
• Antibe Therapeutics
• Astellas Pharma
• Athersys
• Avita Medical
• AxoGen
• Bacterin International
• Baxter
• Bellicum Pharmaceuticals
• BioCardia
• Biogen Idec
• BioRestorative Therapies
• Biostage Technologies
• Bluebird Bio
• BONESUPPORT
• BrainStorm Cell Therapeutics
• Caladrius Biosciences
• Calimmune
• Capricor Therapeutics
• Celgene
• Cell Medica
• CellSeed
• Cell Therapy
• Celyad
• CESCA THERAPEUTICS
• CRC for Cell Therapy Manufacturing
• Cryolife
• Cynata Therapeutics
• Cytori Therapeutics
• Dendreon
• DiscGenics
• Fate Therapeutics
• Fibrocell Science
• Forticell Bioscience
• Fortress Biotech
• FUJIFILM
• Gamida Cell
• Geron
• GlaxoSmithKline
• Healthpoint
• Histogen
• Histogenics
• Holostem Terapie Avanzate
• Humacyte
• ImmunoCellular Therapeutics
• Integra LifeSciences
• Intercytex
• InVivo Therapeutics
• iSTO Technologies
• Janssen Pharma
• Juno Therapeutics
• Juventas Therapeutics
• Kensey Nash
• Kiadis Pharma
• Kinetic Concept
• LifeCell
• LifeNet Health
• Living Cell Technologies
• Lonza
• MaxCyte
• MEDIPOST
• Mesoblast
• Nanofiber Solutions CTO
• Nanotope
• NeoStem
• Neuralstem
• Newlink Genetics
• Northwest Biotherapeutics
• NovaRx
• Ocata Therapeutics
• Opexa Therapeutics
• Organovo Holdings
• Orteg
• Orthofix
• Osiris Therapeutics
• Osteotech
• Pfizer
• Pharmicell
• Pluristem Therapeutics
• Prima BioMed
• Q Therapeutics
• Regenerex
• Regenerys
• Regience
• Regrow
• Replicel
• ReproCELL
• Renova Therapeutics
• RhinoCyte
• Rohto Pharmaceutical
• RTI Surgical
• SanBio
• Sangamo BioSciences
• Shanghai Sunway Biotech
• Shire Regenerative Medicine
• StemCells
• Stratech
• Takara Bio
• TEI Biosciences
• tella
• Tengion
• Tissue Genesis
• TissueGene
• Txcell
• VentriNova
• Vericel
• ViaCyte
• Vistagen
Market driver
• Increased focus on cell therapy products
• For a full, detailed list, view our report
Market challenge
• High cost and failure rate in clinical trials
• For a full, detailed list, view our report
Market trend
• Increased number of regenerative medicine in product line
• For a full, detailed list, view our report
Key questions answered in this report
• What will the market size be in 2020 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?
You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.
PART 01: Executive summary
• Highlights
PART 02: Scope of the report
• Market overview
• Top-vendor offerings
PART 03: Market research methodology
• Research methodology
• Economic indicators
PART 04: Introduction
• Key market highlights
PART 05: Pipeline portfolio
• Pipeline analysis
PART 06: Market landscape
• Market overview
• Market size and forecast
• Five forces analysis
PART 07: Market segmentation by product
• Cell therapy
• Ethical issues of stem cell research
• Global cell therapy market
• Tissue scaffold
• Global tissue scaffold market
• Gene therapy
• Gene therapy market in Europe
PART 08: Market segmentation by application
• Dermatology
• Musculoskeletal
• Ocular
• Cardiovascular
PART 09: Geographical segmentation
• Regenerative medicine market in Americas
• Regenerative medicine market in EMEA
• Regenerative medicine market in APAC
PART 10: Market drivers
• Increased prevalence of chronic diseases
• Funding by governments in regenerative medicine
• Increased focus on cell therapy products
• Technological innovations
PART 11: Impact of drivers
PART 12: Market challenges
• Stringent regulatory standards impeding product approvals
• Ethical challenges in stem cell research
• High cost and failure rate in clinical trials
PART 13: Impact of drivers and challenges
PART 14: Market trends
• Increase in strategic alliances
• Increased number of regenerative medicine in the pipeline
• Gene therapy trending toward geographic expansion
PART 15: Vendor landscape
• Competitive scenario
• Acelity
• Medtronic
• MiMedx Group
• Organogenesis
• UniQure
• Zimmer Biomet
• Other prominent vendors
PART 16: Appendix
• List of abbreviations
PART 17: Explore Technavio
List of Exhibits
Exhibit 01: Product offerings
Exhibit 02: Overview of key sectors involved in regenerative medicine
Exhibit 03: Key sectors in regenerative medicine 2015
Exhibit 04: SBIR and STTR programs
Exhibit 05: Clinical trials 2014
Exhibit 06: Number of clinical trials and products in regenerative medicine market 2014
Exhibit 07: Pipeline of regenerative medicines for CVDs
Exhibit 08: Pipeline of regenerative medicines for central nervous system, orthopedic, and ocular disorders
Exhibit 09: Pipeline of regenerative medicines for dermatology and diabetes
Exhibit 10: Pipeline of regenerative medicines for oncology
Exhibit 11: Global regenerative medicine market 2015-2020 ($ billions)
Exhibit 12: Five forces analysis
Exhibit 13: Global regenerative medicine market by product
Exhibit 14: Global regenerative medicine market by product 2015
Exhibit 15: Cell therapy: Overview
Exhibit 16: Ethical issues faced in different cell therapy research category
Exhibit 17: Stem cell research policies in emerging countries in Americas
Exhibit 18: Stem cell research policies in EMEA
Exhibit 19: Stem cell research policies in APAC
Exhibit 20: Key cell therapy products marketed in the US
Exhibit 21: Key cell therapy products marketed in EMEA
Exhibit 22: Key marketed cell therapy products in APAC
Exhibit 23: Opportunity analysis of cell therapy in global regenerative medicine market
Exhibit 25: Collaborations for R&D of tissue scaffold
Exhibit 26: Opportunity analysis of tissue scaffold in regenerative medicine market
Exhibit 27: Global tissue scaffold market 2015-2020 ($ billions)
Exhibit 28: Recent M&A in tissue scaffold market
Exhibit 29: Gene therapy products in Europe
Exhibit 30: Opportunity analysis of gene therapy in global regenerative medicine market
Exhibit 31: Gene therapy market in Europe 2015-2020 ($ billions)
Exhibit 32: European Commission support in gene transfer and gene therapy projects
Exhibit 33: Global regenerative medicine market by application
Exhibit 34: Global regenerative medicine market by application 2015
Exhibit 35: Overview of dermatology segment in global regenerative medicine market
Exhibit 36: Pipeline of regenerative medicine for dermatology
Exhibit 37: Overview of musculoskeletal segment in global regenerative medicine market
Exhibit 38: Overview of ocular segment in global regenerative medicine market
Exhibit 39: Overview of cardiovascular segment in global regenerative medicine market
Exhibit 40: Global regenerative medicine market by geography 2015
Exhibit 41: Global regenerative medicine market by geography 2020
Exhibit 42: Funding by federal agencies for R&D of regenerative medicine 2014 ($ millions)
Exhibit 43: Regenerative medicine market in Americas 2015-2020 ($ billions)
Exhibit 44: Distribution of 45 cell therapy vendors in Europe 2011
Exhibit 45: Regenerative medicine market in EMEA 2015-2020 ($ billions)
Exhibit 46: Regenerative medicine market in APAC 2015-2020 ($ billions)
Exhibit 47: Key developments in regenerative medicine market in Japan 2015
Exhibit 48: Global regenerative medicine market by geography 2015-2020
Exhibit 49: Global regenerative medicine market by geography 2015-2020 ($ billions)
Exhibit 50: Breakdown of CIRM funding in various stem cell research studies 2014 ($ billions)
Exhibit 51: Active programs under CIRM 2014
Exhibit 52: Funding by European Commission for regenerative medicine
Exhibit 53: Impact of drivers
Exhibit 54: Impact of drivers and challenges
Exhibit 55: Major strategic alliances in global regenerative medicine market
Exhibit 56: Mid- and late-stage pipeline products for regenerative medicine
Exhibit 57: Clinical trials on gene therapy for various indications
Exhibit 58: Vendors in global regenerative medicine market
Exhibit 59: Acelity: Business segmentation by revenue 2015
Exhibit 60: Acelity: Regenerative medicine revenues and YoY growth rate 2013-2015 ($ millions)
Exhibit 61: Acelity: Metrics analysis
Exhibit 62: Medtronic: Metrics analysis
Exhibit 63: MiMedx Group: Metrics analysis
Exhibit 64: Organogenesis: Metrics analysis
Exhibit 65: UniQure: Metrics analysis
Exhibit 66: Zimmer Biomet: Metrics analysis
Exhibit 67: Other prominent vendors
